BioThera Solutions

BioThera Solutions is a Canadian biotechnology company specializing in extracellular vesicle biomanufacturing. It operates a plant-derived extracellular vesicle biomanufacturing platform, with characterization against MISEV2023 standards. The company is based in Ottawa, Canada.

BioThera Solutions was founded to address a critical gap in the extracellular vesicle (EV/exosome) field: the absence of scalable, standardized, and reproducible manufacturing required to bring EV technologies into real-world application. The company operates across three integrated layers: plant-derived EV isolation and MISEV2023-compliant biomanufacturing, rigorous particle characterization, and formulation into finished applications. The same workflow supplies every application built on the platform, and every batch leaves with the Certificate of Analysis behind it.

1. 1Plant-Derived Extracellular Vesicle Biomanufacturing Platform | BioThera Solutionsbiotherasolutions.com
2. 2About — Plant-Derived EV Biotech Founded in Ottawa | BioThera Solutionsbiotherasolutions.com
3. 3BioThera Solutionswikidata.org
4. 4百奥泰启动H股上市进程 科创板创新药企欲“A+H”阔步国际化finance.sina.com.cn
5. 5百奥泰启动H股上市进程 科创板创新药企欲“A+H”阔步国际化finance.sina.com.cn
6. 6百奥泰启动H股上市进程 科创板创新药企欲“A+H”阔步国际化tech.sina.com.cn
7. 7百奥泰与百济神州宣布就安维汀（贝伐珠单抗）生物类似药BAT1706签订在中国的授权、分销、供货协议finance.sina.com.cn
8. 8科创板|百奥泰、石头科技科创板IPO通过上市委审核，雷军再入手一家科创板上市公司finance.sina.com.cn
9. 9坐拥“药王”首仿百奥泰闯荡科创板 修美乐提前降价搅动阿达木单抗市场风云finance.sina.com.cn
10. 10Bio-Thera Solutions Partners With Hikma To Commercialize BAT2206finanznachrichten.de
11. 11Bio-Thera Solutions, Ltd.: Bio-Thera Solutions Expands Partnership with Pharmapark in Russia and other CIS Countries with Addition of BAT2206, a Stelara Biosimilarfinanznachrichten.de